The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Transcriptomic Signatures in Sepsis and a Differential Response to Steroids. From the VANISH Randomized Trial
Open accessAbstract
RATIONALE: There remains uncertainty about the role of corticosteroids in sepsis with clear beneficial effects on shock duration, but conflicting survival effects. Two transcriptomic sepsis response signatures (SRSs) have been identified. SRS1 is relatively immunosuppressed, whereas SRS2 is relatively immunocompetent. OBJECTIVES: We aimed to categorize patients based on SRS endotypes to determine if these profiles influenced response to either norepinephrine or vasopressin, or to corticosteroids in septic shock. METHODS: A post hoc analysis was performed of a double-blind, randomized clinical trial in septic shock (VANISH [Vasopressin vs. Norepinephrine as Initial Therapy in Septic Shock]). Patients were included within 6 hours of onset of shock and were randomized to receive norepinephrine or vasopressin followed by hydrocortisone or placebo. Genome-wide gene expression profiling was performed and SRS endotype was determined by a previously established model using seven discriminant genes. MEASUREMENTS AND MAIN RESULTS: Samples were available from 176 patients: 83 SRS1 and 93 SRS2. There was no significant interaction between SRS group and vasopressor assignment (P = 0.50). However, there was an interaction between assignment to hydrocortisone or placebo, and SRS endotype (P = 0.02). Hydrocortisone use was associated with increased mortality in those with an SRS2 phenotype (odds ratio = 7.9; 95% confidence interval = 1.6-39.9). CONCLUSIONS: Transcriptomic profile at onset of septic shock was associated with response to corticosteroids. Those with the immunocompetent SRS2 endotype had significantly higher mortality when given corticosteroids compared with placebo. Clinical trial registered with www.clinicaltrials.gov (ISRCTN 20769191).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
limma powers differential expression analyses for RNA-sequencing and microarray studies
Ritchie, M. E., Phipson, B., Wu, D., Hu, Y., Law, C. W., Shi, W., & Smyth, G. K. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv007 · Cited by 40,458
The third international consensus definitions for sepsis and septic shock (Sepsis-3).
Singer, M., Deutschman, C. S., Seymour, C. W., Shankar-Hari, M., Annane, D., Bauer, M., Bellomo, R., Bernard, G. R., Chiche, J.-D., Coopersmith, C. M., et al. (2016) · JAMA · doi:10.1001/jama.2016.0287 · Cited by 28,250
Hydrocortisone Therapy for Patients with Septic Shock
Sprung, C. L., Annane, D., Keh, D., Moreno, R., Singer, M., Freivogel, K., Weiss, Y. G., Benbenishty, J., Kalenka, A., Forst, H., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa071366 · Cited by 2,132
Adjunctive glucocorticoid therapy in patients with septic shock.
Venkatesh, B., Finfer, S., Cohen, J., Rajbhandari, D., Arabi, Y., Bellomo, R., Billot, L., Correa, M., Glass, P., Harward, M., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1705835 · Cited by 1,037
Hydrocortisone plus fludrocortisone for adults with septic shock.
Annane, D., Renault, A., Brun-Buisson, C., Megarbane, B., Quenot, J.-P., Siami, S., Cariou, A., Forceville, X., Schwebel, C., Martin, C., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1705716 · Cited by 939
Genomic landscape of the individual host response and outcomes in sepsis: a prospective cohort study
Davenport, E. E., Burnham, K. L., Radhakrishnan, J., Humburg, P., Hutton, P., Mills, T. C., Rautanen, A., Gordon, A. C., Garrard, C., Hill, A. V. S., et al. (2016) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(16)00046-1 · Cited by 856
Self-citationGordon, A. C., Mason, A. J., Thirunavukkarasu, N., Perkins, G. D., Cecconi, M., Cepkova, M., Pogson, D. G., Aya, H. D., Anjum, A., Frazier, G. J., et al. (2016) · JAMA · doi:10.1001/jama.2016.10485 · Cited by 728
Self-citationUpdate on glucocorticoid action and resistance
Nelson, H. S., Leung, D. Y. M., & Bloom, J. W. (2003) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2003.97 · Cited by 413
Sweeney, T. E., Azad, T. D., Donato, M., Haynes, W. A., Perumal, T. M., Henao, R., Bermejo-Martin, J. F., Almansa, R., Tamayo, E., Howrylak, J. A., et al. (2018) · Critical Care Medicine · doi:10.1097/ccm.0000000000003084 · Cited by 362
Developing a Clinically Feasible Personalized Medicine Approach to Pediatric Septic Shock
Wong, H. R., Cvijanovich, N. Z., Anas, N., Allen, G. L., Thomas, N. J., Bigham, M. T., Weiss, S. L., Fitzgerald, J., Checchia, P. A., Meyer, K., et al. (2015) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201410-1864oc · Cited by 324
Shared and Distinct Aspects of the Sepsis Transcriptomic Response to Fecal Peritonitis and Pneumonia
Burnham, K. L., Davenport, E. E., Radhakrishnan, J., Humburg, P., Gordon, A. C., Hutton, P., Svoren-Jabalera, E., Garrard, C., Hill, A. V. S., Hinds, C. J., et al. (2017) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201608-1685oc · Cited by 249
Self-citationMonocyte Human Leukocyte Antigen–DR Transcriptional Downregulation by Cortisol during Septic Shock
Le Tulzo, Y., Pangault, C., Amiot, L., Guilloux, V., Tribut, O., Arvieux, C., Camus, C., Fauchet, R., Thomas, R., & Drénou, B. (2004) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200309-1329oc · Cited by 166
Cell-surface signatures of immune dysfunction risk-stratify critically ill patients: INFECT study
Morris, A. C., Datta, D., Shankar‐Hari, M., Stephen, J., Weir, C. J., Rennie, J., Antonelli, J., Bateman, A. P., Warner, N. L., Judge, K. W., et al. (2018) · Intensive Care Medicine · doi:10.1007/s00134-018-5247-0 · Cited by 133
Gordon, A. C., Mason, A. J., Perkins, G. D., Stotz, M., Terblanche, M., Ashby, D., & Brett, S. J. (2014) · Critical Care Medicine · doi:10.1097/ccm.0000000000000212 · Cited by 128
Self-citationvan de Garde, M. D. B., Martínez, F. O., Melgert, B. N., Hylkema, M. N., Jonkers, R. E., & Hamann, J. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1302138 · Cited by 120
Gordon, A. C., Mason, A. J., Perkins, G. D., Ashby, D., & Brett, S. J. (2014) · BMJ Open · doi:10.1136/bmjopen-2014-005866 · Cited by 25
Self-citationLim, T. K. Y., Chen, G., McDonald, R. A., & Toews, G. B. (1996) · Stem Cells · doi:10.1002/stem.140292 · Cited by 15
Correction: Corrigendum: Effects of Systemically Administered Hydrocortisone on the Human Immunome
Olnes, M. J., Kotliarov, Y., Biancotto, A., Cheung, F., Chen, J., Shi, R., Zhou, H., Wang, E., Tsang, J. S., Nussenblatt, R. B., et al. (2016) · Scientific Reports · doi:10.1038/srep25215 · Cited by 14
Cited by
van der Poll, T., Shankar-Hari, M., & Wiersinga, W. J. (2021) · Immunity · doi:10.1016/j.immuni.2021.10.012 · Cited by 1,010
Large-Scale Multi-omic Analysis of COVID-19 Severity
Overmyer, K. A., Shishkova, E., Miller, I. J., Balnis, J., Bernstein, M. N., Peters-Clarke, T. M., Meyer, J. G., Quan, Q., Muehlbauer, L. K., Trujillo, E. A., et al. (2021) · Cell Systems · doi:10.1016/j.cels.2020.10.003 · Cited by 606
Meyer, N. J., & Prescott, H. C. (2024) · New England Journal of Medicine · doi:10.1056/nejmra2403213 · Cited by 395
Prognostic and predictive enrichment in sepsis
Stanski, N. L., & Wong, H. R. (2020) · Nature Reviews Nephrology · doi:10.1038/s41581-019-0199-3 · Cited by 393
The pathophysiology of sepsis and precision-medicine-based immunotherapy
Giamarellos-Bourboulis, E. J., Aschenbrenner, A. C., Bauer, M., Bock, C., Calandra, T., Gat-Viks, I., Kyriazopoulou, E., Lupse, M., Monneret, G., Pickkers, P., et al. (2024) · Nature Immunology · doi:10.1038/s41590-023-01660-5 · Cited by 374
Metadata
- Authors
- Antcliffe, D. B., Burnham, K. L., Al-Beidh, F., Santhakumaran, S., Brett, S. J., Hinds, C. J., Ashby, D., Knight, J. C., & Gordon, A. C.
- Venue
- American Journal of Respiratory and Critical Care Medicine
- Publisher
- Oxford University Press (OUP)
- Published
- 2019-04-15
- Volume
- 199
- Issue
- 8
- Pages
- 980-986
- ISSN
- 1073-449X (ISSN-L)
- 1535-4970
- OpenAlex
- W2898483928
- Cited by
- 365
- References
- 18
- FWCI
- 13.30
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.